Uveitis;Uvéites

Presse Medicale

Volumn 41, Issue 1, 2012, Pages 10-20

  Brézin, Antoine P ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL FEATURE; DISEASE SEVERITY; EYE INFECTION; HUMAN; PHENOTYPE; PROGNOSIS; RETINA MACULA LUTEA; SHORT SURVEY; UVEITIS;

BEHCET SYNDROME; EYE FOREIGN BODIES; EYE INJURIES; HUMANS; INFECTION; INFLAMMATION; INTESTINAL DISEASES; MODELS, BIOLOGICAL; UVEITIS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 84855514967     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lpm.2011.05.011     Document Type: Short Survey

References (29)

1. Gritz D.C., Wong I.G. Incidence and prevalence of uveitis in Northern California; the Northern California Epidemiology of Uveitis Study. Ophthalmology 2004, 111:491-500.
2. Suttorp-Schulten M.S.A., Rothova A. The possible impact of uveitis in blindness: a literature survey. Br J Ophthalmol 1996, 80:844-848.
3. Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol 1996, 80:332-336.
4. Jabs D.A., Nussenblatt R.B., Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005, 140:509-516. Standardization of Uveitis Nomenclature (SUN) Working Group.
5. Monnet D., Breban M., Hudry C., Dougados M., Brézin A.P. Ophthalmic findings and frequency of extraocular manifestations in patients with HLA-B27uveitis: a study of 175cases. Ophthalmology 2004, 111:802-809.
6. Braun J., Baraliakos X., Listing J., Sieper J. Decreased incidence of anterior uveitis in patients with ankylosing spondylitis treated with the anti-tumor necrosis factor agents infliximab and etanercept. Arthritis Rheum 2005, 52:2447-2451.
7. Galor A., Perez V.L., Hammel J.P., Lowder C.Y. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation. Ophthalmology 2006, 113:2317-2323.
8. Monnet D., Moachon L., Dougados M., Brézin A.P. Severe uveitis in an HLA-B27-positive patient with ankylosing spondylitis. Nat Clin Pract Rheumatol 2006, 2:393-397.
9. Tugal-Tutkun I., Onal S., Altan-Yaycioglu R., Huseyin Altunbas H., Urgancioglu M. Uveitis in Behcet disease: an analysis of 880patients. Am J Ophthalmol 2004, 138:373-380.
10. Lyons J.L., Rosenbaum J.T. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondylarthropathy. Arch Ophthalmol 1997, 115:61-64.
11. Abad S., Meyssonier V., Allali J., Gouya H., Giraudet A.L., Monnet D., et al. Association of peripheral multifocal choroiditis with sarcoidosis: a study of thirty-seven patients. Arthritis Rheum 2004, 51:974-982.
12. Read R.W., Holland G.N., Rao N.A., Tabbara K.F., Ohno S., Arellanes-Garcia L., et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001, 131:647-652.
13. Abad S., Monnet D., Caillat-Zucman S., Mrejen S., Blanche P., Chalumeau M., et al. Characteristics of Vogt-Koyanagi-Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm 2008, 16:3-8.
14. Smith J.R., Rosenbaum J.T. Neurological concomitants of uveitis. Br J Ophthalmol 2004, 88:1498-1499.
15. BenEzra D., Cohen E., Maftzir G. Uveitis in children and adolescents. Br J Ophthalmol 2005, 89:444-448.
16. Levinson R.D., Brézin A.P., Rothova A., Accorinti M., Holland G.N. Research criteria for the diagnosis of birdshot chorioretinopathy: results of an international consensus conference. Am J Ophthalmol 2006, 141:185-187.
17. Wolf M.D., Alward W.L., Folk J.C. Long-term visual function in acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1991, 109:800-803.
18. Lim W.K., Buggage R.R., Nussenblatt R.B. Serpiginous choroiditis. Surv Ophthalmol 2005, 50:231-244.
19. Chan C.C., Roberge R.G., Whitcup S.M., Nussenblatt R.B. 32cases of sympathetic ophthalmia. A retrospective study at the National Eye Institute, Bethesda, Md, from 1982to 1992. Arch Ophthalmol 1995, 113:597-600.
20. Mohamed Q., Zamir E. Update on Fuchs' uveitis syndrome. Curr Opin Ophthalmol 2005, 16:356-363.
21. Prieto J.F., Dios E., Gutierrez J.M., Mayo A., Calonge M., Herreras J.M. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 2001, 9:93-102.
22. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part I: epidemiology and course of disease. Am J Ophthalmol 2003, 136:973-988.
23. Holland G.N. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol 2004, 137:1-17.
24. Stewart J.M., Cubillan L.D., Cunningham E.T. Prevalence, clinical features, and causes of vision loss among patients with ocular toxocariasis. Retina 2005, 25:1005.
25. Ganatra J.B., Chandler D., Santos C., Kuppermann B., Margolis T.P. Viral causes of the acute retinal necrosis syndrome. Am J Ophthalmol 2000, 129:166-172.
26. Merle H., Cabre P., Olindo S., Merle S., Smadja D. Ocular lesions in 200patients infected by the human T-cell lymphotropic virus type 1in Martinique (French West Indies). Am J Ophthalmol 2002, 134:190-195.
27. Sheu S.J., Shyu J.S., Chen L.M., Chen Y.Y., Chirn S.C., Wang J.S. Ocular manifestations of tuberculosis. Ophthalmology 2001, 108:1580-1585.
28. Browning D.J. Posterior segment manifestations of active ocular syphilis, their response to a neurosyphilis regimen of penicillin therapy, and the influence of human immunodeficiency virus status on response. Ophthalmology 2000, 107:2015-2023.
29. Park S., Abad S., Tulliez M., Monnet D., Merlat A., Gyan E., et al. Pseudouveitis: a clue to the diagnosis of primary central nervous system lymphoma in immunocompetent patients. Medicine (Baltimore) 2004, 83:223-232.